Boulegeris Investments’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-950
| Closed | -$328K | – | 40 |
|
|
2018
Q2 | $328K | Buy |
950
+80
| +9% | +$27.6K | 0.16% | 47 |
|
|
2018
Q1 | $300K | Sell |
870
-30
| -3% | -$10.3K | 0.16% | 47 |
|
|
2017
Q4 | $338K | Sell |
900
-5
| -0.6% | -$1.88K | 0.18% | 44 |
|
|
2017
Q3 | $405K | Buy |
905
+10
| +1% | +$4.48K | 0.23% | 43 |
|
|
2017
Q2 | $440K | Hold |
895
| – | – | 0.25% | 41 |
|
|
2017
Q1 | $347K | Sell |
895
-675
| -43% | -$262K | 0.21% | 41 |
|
|
2016
Q4 | $576K | Sell |
1,570
-145
| -8% | -$53.2K | 0.35% | 35 |
|
|
2016
Q3 | $689K | Buy |
1,715
+130
| +8% | +$52.2K | 0.44% | 35 |
|
|
2016
Q2 | $554K | Buy |
1,585
+230
| +17% | +$80.4K | 0.38% | 35 |
|
|
2016
Q1 | $488K | Buy |
1,355
+680
| +101% | +$245K | 0.34% | 36 |
|
|
2015
Q4 | $366K | Buy |
675
+105
| +18% | +$56.9K | 0.27% | 38 |
|
|
2015
Q3 | $265K | Buy |
+570
| New | +$265K | 0.2% | 42 |
|